Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Generative AI tools for doctors consolidate as Doximity acquires Pathway

0 Mins
In STAT's Health Tech newsletter: Doximity acquires Pathway, Omada's first earnings call, and Abridge’s Highmark deal
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago